Cargando…

LSD1 inhibition suppresses the growth of clear cell renal cell carcinoma via upregulating P21 signaling

Histone lysine-specific demethylase 1 (LSD1) has been implicated in the disease progression of several types of solid tumors. This study provides the first evidence showing that LSD1 overexpression occurred in 62.6% (224/358) of clear cell renal cell carcinomas (ccRCC). LSD1 expression was associate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Liangsong, Wang, Jianfeng, Kong, Wen, Huang, Jiwei, Dong, Baijun, Huang, Yiran, Xue, Wei, Zhang, Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437640/ https://www.ncbi.nlm.nih.gov/pubmed/30972280 http://dx.doi.org/10.1016/j.apsb.2018.10.006

Ejemplares similares

High Expression of Stearoyl-CoA Desaturase 1 Predicts Poor Prognosis in Patients with Clear-Cell Renal Cell Carcinoma
por: Wang, Jianfeng, et al.
Publicado: (2016)

TIKI2 is upregulated and plays an oncogenic role in renal cell carcinoma
por: Yuan, Xiaodong, et al.
Publicado: (2016)

SUV39H1 deficiency suppresses clear cell renal cell carcinoma growth by inducing ferroptosis
por: Wang, Jianfeng, et al.
Publicado: (2021)

Preoperative evaluation of renal artery in patients with renal tumor: Using noncontrast-enhanced magnetic resonance angiography
por: Zhu, Liangsong, et al.
Publicado: (2016)

Comprehensive Genomic Landscape in Chinese Clear Cell Renal Cell Carcinoma Patients
por: Huang, Jiwei, et al.
Publicado: (2021)

SENP1 promotes proliferation of clear cell renal cell carcinoma through activation of glycolysis
por: Dong, Baijun, et al.
Publicado: (2016)

Comparison of efficacy, safety, and quality of life between sorafenib and sunitinib as first-line therapy for Chinese patients with metastatic renal cell carcinoma
por: Cai, Wen, et al.
Publicado: (2017)

ZHX2 drives cell growth and migration via activating MEK/ERK signal and induces Sunitinib resistance by regulating the autophagy in clear cell Renal Cell Carcinoma
por: Zhu, Liangsong, et al.
Publicado: (2020)

Cyclin-dependent kinase 5 acts as a promising biomarker in clear cell Renal Cell Carcinoma
por: Zhu, Liangsong, et al.
Publicado: (2019)

Correction: ZHX2 drives cell growth and migration via activating MEK/ERK signal and induces Sunitinib resistance by regulating the autophagy in clear cell Renal Cell Carcinoma
por: Zhu, Liangsong, et al.
Publicado: (2021)

Upregulation of CD11b and CD86 through LSD1 inhibition promotes myeloid differentiation and suppresses cell proliferation in human monocytic leukemia cells
por: Fang, Jianwu, et al.
Publicado: (2017)

The selective MEK1 inhibitor Selumetinib enhances the antitumor activity of everolimus against renal cell carcinoma in vitro and in vivo
por: Zou, Yun, et al.
Publicado: (2017)

Upregulation of CENPM is associated with poor clinical outcome and suppression of immune profile in clear cell renal cell carcinoma
por: Zhang, Zhi-Cheng, et al.
Publicado: (2023)

RNA Sequencing Reveals Upregulation of RUNX1-RUNX1T1 Gene Signatures in Clear Cell Renal Cell Carcinoma
por: Xiong, Zuquan, et al.
Publicado: (2014)

Serum extracellular vesicles derived hsa-miR-320d as an indicator for progression of clear cell renal cell carcinoma
por: Xue, Yizheng, et al.
Publicado: (2023)

Sphingosine kinase 1 is overexpressed and promotes adrenocortical carcinoma progression
por: Xu, Yunze, et al.
Publicado: (2015)

Characterization of Molecular Heterogeneity Associated With Tumor Microenvironment in Clear Cell Renal Cell Carcinoma to Aid Immunotherapy
por: Zhong, Weimin, et al.
Publicado: (2021)

VHL and DNA damage repair pathway alterations as potential clinical biomarkers for first-line TKIs in metastatic clear cell renal cell carcinomas
por: Zhou, Jiale, et al.
Publicado: (2022)

Lsd1 safeguards T-cell development via suppressing endogenous retroelements and interferon responses
por: Xia, Miaoran, et al.
Publicado: (2023)

Suppression of intrahepatic cholangiocarcinoma cell growth by SKI via upregulation of the CDK inhibitor p21
por: Kawamura, Etsushi, et al.
Publicado: (2022)

Downregulation of VEGFA inhibits proliferation, promotes apoptosis, and suppresses migration and invasion of renal clear cell carcinoma
por: Zeng, Fan-Chang, et al.
Publicado: (2016)

LSD1 Promotes Bladder Cancer Progression by Upregulating LEF1 and Enhancing EMT
por: Xie, Qiubo, et al.
Publicado: (2020)

Association of post-treatment hypoalbuminemia and survival in Chinese patients with metastatic renal cell carcinoma
por: Cai, Wen, et al.
Publicado: (2017)

Major histocompatibility complex I upregulation in clear cell renal cell carcinoma is associated with increased survival
por: Sekar, Rishi R., et al.
Publicado: (2016)

Overexpression of DBT suppresses the aggressiveness of renal clear cell carcinoma and correlates with immune infiltration
por: Zhang, Chiyu, et al.
Publicado: (2023)

Upregulation of homeobox D10 expression suppresses invasion and migration of clear cell renal cell carcinoma through targeting of E-cadherin
por: Ren, Zongtao, et al.
Publicado: (2021)

Pharmacological inhibition of LSD1 suppresses growth of hepatocellular carcinoma by inducing GADD45B
por: Sang, Na, et al.
Publicado: (2023)

Transitional cell carcinoma with extension of the renal vein and IVC tumor thrombus: report of three cases and literature review
por: Li, Mingyang, et al.
Publicado: (2016)

Demethylase-independent roles of LSD1 in regulating enhancers and cell fate transition
por: Zeng, Cheng, et al.
Publicado: (2023)

Sanguinarine, identified as a natural alkaloid LSD1 inhibitor, suppresses lung cancer cell growth and migration
por: Qin, Ting-ting, et al.
Publicado: (2022)

The iron-modulating hormone hepcidin is upregulated and associated with poor survival outcomes in renal clear cell carcinoma
por: Huang, Jian, et al.
Publicado: (2022)

NDRG2 suppresses the proliferation of clear cell renal cell carcinoma cell A-498
por: Ma, Jian-Jun, et al.
Publicado: (2010)

Pathologic analysis of non-neoplastic parenchyma in renal cell carcinoma: a comprehensive observation in radical nephrectomy specimens
por: Wang, Xun, et al.
Publicado: (2017)

Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma
por: Du, Yiqing, et al.
Publicado: (2017)

Upregulation of TMEM45A Promoted the Progression of Clear Cell Renal Cell Carcinoma in vitro
por: Jiang, Huiming, et al.
Publicado: (2021)

Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis
por: Cui, Yuanshan, et al.
Publicado: (2021)

PRMT1 is a novel molecular therapeutic target for clear cell renal cell carcinoma
por: Wang, Jianfeng, et al.
Publicado: (2021)

Anterograde regulation of mitochondrial genes and FGF21 signaling by hepatic LSD1
por: Cao, Yang, et al.
Publicado: (2021)

ASS1 and ASL suppress growth in clear cell renal cell carcinoma via altered nitrogen metabolism
por: Khare, Sanika, et al.
Publicado: (2021)

SP2509, a Selective Inhibitor of LSD1, Suppresses Retinoblastoma Growth by Downregulating β-catenin Signaling
por: Jiang, Alan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0n5dp7u74cf7phlgplebfkc9d9